Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes (PROGETE)
Diabetes Mellitus, Type I, Program Evaluation, Therapeutic Education
About this trial
This is an interventional supportive care trial for Diabetes Mellitus, Type I focused on measuring Evaluation, Therapeutic education, Type 1 Diabetes, Children
Eligibility Criteria
Inclusion Criteria:
- Enrollment between January 15 to March 15, 2016
- Insulin-dependent type 1 Diabetes
- Treatment received at the Hospital of Mulhouse, France
Exclusion Criteria:
- Opposition to study participation
- Behavioral issues
- Uncontrolled psychological issue
Sites / Locations
- GHRMSA
Arms of the Study
Arm 1
Other
Enrolled patient
Every patient of the Mulhouse Hospital with a type 1 diabetes who joins the study will be followed for 10 months. They will fill in the DIAPASON questionnaire and the quality of life WHO-5 questionnaire on the day of enrollment and 10 months after enrollment, at the end of the study. Young patients followed for a type 1 diabetes at the Mulhouse Hospital usually come every two months to see the pediatric endocrinologist, so the data collected for a regular visit will also be collected for the study every two months between the enrollment and the end of study participation.